Loading
Chronic Disease Management Strategies · Journal article
Chinese General Practice Journal. · September 3, 2026
A consensus or society position rather than new primary data.
This systematic review maps the evolution of multimorbidity research in Chinese primary care over 16 years (2009–2025), documenting progression from concept introduction through integrated management, and identifies persistent evidence gaps and systems-level barriers. The work is primarily descriptive and agenda-setting rather than efficacy-focused, establishing a roadmap for future intervention development and health system integration in the context of China's ageing population.
Systematic review. Published research on multimorbidity in general practice and primary health care settings in mainland China.. Intervention: Multimorbidity research and intervention practices across four developmental stages.. Mainland China.
Research on multimorbidity in China has evolved through four distinct stages: concept introduction, descriptive epidemiology, intervention exploration, and integrated management. Critical gaps persist in high-quality intervention evidence, standardized clinical guidelines, integrated information systems, and professional workforce capacity. Community-based frameworks balancing service supply with patient needs have begun to emerge but remain incomplete.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians and health systems should use this synthesis to recognize that multimorbidity management in China is transitioning from disease-specific to integrated approaches, and that investment in high-quality evidence, standardized guidelines, and data infrastructure is essential to support this shift.
A systematic review of multimorbidity research in China that synthesizes evidence trajectory, identifies gaps, and recommends priorities for clinical practice and policy, but does not report new primary efficacy or safety data.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians and health systems should use this synthesis to recognize that multimorbidity management in China is transitioning from disease-specific to integrated approaches, and that investment in high-quality evidence, standardized guidelines, and data infrastructure is essential to support this shift.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Multimorbidity, defined as the coexistence of two or more chronic conditions in a single individual, has become a major public-health challenge in ageing societies. The management of such complex health states relies fundamentally on primary health care services; however, the intricate interplay of coexisting diseases imposes substantial demands on the capacity and competency of these services. Adhering to PRISMA guidelines, this study systematically reviewed literature from mainland-China (2009–2025) situated within general-practice and primary health care settings. We summarized the developmental trajectory, research hotspots and intervention practices regarding multimorbidity, utilizing a SWOT framework to analyze the strengths, weaknesses, opportunities and threats inherent to general practice in this domain. The review showed that research on multimorbidity in China has evolved through four stages: concept introduction, descriptive epidemiology, intervention exploration, and integrated management. While a community-based framework balancing service supply with patient needs has begun to emerge, critical gaps persist regarding high-quality intervention evidence, standardized clinical guidelines, integrated information systems and professional workforce. Future priorities should be the construction of high-quality primary health care data platforms and the deepening of integrated-care models. This shift is essential to transition chronic disease management from a single-disease management toward a synergistic, multimorbidity—focused approach, thereby fostering a more profound integration of clinical care and public health.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.